LY 203647

Known as: LY-203647, LY203647 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-1995
012319891995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Previous studies have indicated that tumor necrosis factor-alpha (TNF-alpha) may play a pathophysiologic role in experimental… (More)
Is this relevant?
1994
1994
The potential role of tumor necrosis factor alpha (TNF alpha) and eicosanoids in the pathogenesis of experimental neonatal sepsis… (More)
Is this relevant?
1993
1993
Ibuprofen and the leukotriene antagonist, LY203647, were used to evaluate the effectiveness of LY203647 in the dual blockade of… (More)
Is this relevant?
1992
1992
In vitro studies have shown LY203647 to be a selective antagonist of contractile responses to leukotriene (LT) D4 and LTE4 in… (More)
Is this relevant?
1991
1991
The sulfidopeptide leukotrienes (LT) have been implicated as important pathophysiological mediators in septic shock. To further… (More)
Is this relevant?
1991
1991
This study investigated the effect of a novel LTD4 receptor antagonist LY203647 on Salmonella enteritidis endotoxin-induced shock… (More)
Is this relevant?
1991
1991
We examined the effect of intravenous infusion of graded doses of authentic leukotriene (LT) C4 on several physiological… (More)
Is this relevant?
1989
1989
LY171883, 1-[2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl] ethanone, is an orally active antagonist of LTD4- and LTE4… (More)
  • figure 1
  • table 1
Is this relevant?